Zubing Chen
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
- Co-authors
- Shiqiang Shen (10 shared papers)Baogang Peng (2 shared papers)Zhirui Zeng (3 shared papers)Li-dan Hao (2 shared papers)Lijian Liang (2 shared papers)Chao Hu (3 shared papers)Youming Ding (2 shared papers)Zi Ye (4 shared papers)
In The Last Decade
Zubing Chen
21 papers receiving 331 citations
Peers
Comparison fields: 5 of 44
- Hepatology 53
- Cancer Research 53
- Oncology 81
- Immunology 66
- Molecular Biology 94
Countries citing papers authored by Zubing Chen
This map shows the geographic impact of Zubing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zubing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zubing Chen more than expected).
Fields of papers citing papers by Zubing Chen
This network shows the impact of papers produced by Zubing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zubing Chen. The network helps show where Zubing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Zubing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 53 | |
| 2 | 2011 | 48 | |
| 3 | 2019 | 26 | |
| 4 | 2008 | 26 | |
| 5 | 2019 | 25 | |
| 6 | 2015 | 24 | |
| 7 | 2020 | 22 | |
| 8 | Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma. | 2007 | 17 |
| 9 | 2015 | 14 | |
| 10 | 2023 | 11 | |
| 11 | 2017 | 11 | |
| 12 | 2015 | 10 | |
| 13 | 2020 | 10 | |
| 14 | 2018 | 8 | |
| 15 | 2018 | 7 | |
| 16 | 2020 | 7 | |
| 17 | 2024 | 6 | |
| 18 | 2019 | 4 | |
| 19 | [Protective effect of magnesium isoglycyrrhizinate combinated with verapamil on liver ischemia-reperfusion injury after semi-hepatectomy in rats]. | 2015 | 2 |
| 20 | 2020 | 2 |
About Zubing Chen
Zubing Chen is a scholar working on Hepatology, Cancer Research, Molecular Biology, Immunology and Surgery, having authored 22 papers that have together received 334 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers), Immune Cell Function and Interaction (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Polyamine Metabolism and Applications (2 papers) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Hepatology (53 citations), Cancer Research (53 citations), Oncology (81 citations), Immunology (66 citations) and Molecular Biology (94 citations). Zubing Chen has collaborated with scholars based in China, Australia and Hong Kong. Frequent co-authors include Shiqiang Shen, Baogang Peng, Zhirui Zeng, Li-dan Hao, Lijian Liang, Chao Hu, Youming Ding, Zi Ye, Wenjie Hu and Wei Li. Their work appears in journals such as International Journal of Hyperthermia, OncoTargets and Therapy, Journal of Laparoendoscopic & Advanced Surgical Techniques, World Journal of Gastroenterology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.